Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Graefen

Showing results (491-500 of 921) with videos related to

Pageof 93
Sort By:
European Urology Focus|February 21, 2021
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma PatientsChristoph Würnschimmel, Claudia Collà Ruvolo, Luigi Nocera, et al.
World Journal of Urology|May 12, 2021
Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicitiesChristoph Würnschimmel, Mike Wenzel, Claudia Collà Ruvolo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 23, 2018
In-hospital length of stay after major surgical oncological proceduresSebastiano Nazzani, Felix Preisser, Elio Mazzone, et al.
World Journal of Urology|March 3, 2018
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patientsJonas Schiffmann, Pierre I Karakiewicz, Michael Rink, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 21, 2014
Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapyJens Hansen, Giorgio Gandaglia, Marco Bianchi, et al.
The Journal of Urology|August 18, 2009
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasisGiovanni Lughezzani, Claudio Jeldres, Hendrik Isbarn, et al.
BMC Cancer|August 18, 2016
Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patientsMaria-Christina Tsourlakis, Annegret Stender, Alexander Quaas, et al.
The Prostate|May 19, 2021
Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Journal of Endourology|April 2, 2019
Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United StatesElio Mazzone, Francesco A Mistretta, Sophie Knipper, et al.
Journal of Endourology|February 7, 2014
Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatmentsGiorgio Gandaglia, Firas Abdollah, Jim Hu, et al.
Pageof 93

Showing results (491-500 of 921) with videos related to

Sort By:
Pageof 93
European Urology Focus|February 21, 2021
Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma PatientsChristoph Würnschimmel, Claudia Collà Ruvolo, Luigi Nocera, et al.
World Journal of Urology|May 12, 2021
Survival advantage of Asian metastatic prostate cancer patients treated with external beam radiotherapy over other races/ethnicitiesChristoph Würnschimmel, Mike Wenzel, Claudia Collà Ruvolo, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 23, 2018
In-hospital length of stay after major surgical oncological proceduresSebastiano Nazzani, Felix Preisser, Elio Mazzone, et al.
World Journal of Urology|March 3, 2018
Obesity paradox in prostate cancer: increased body mass index was associated with decreased risk of metastases after surgery in 13,667 patientsJonas Schiffmann, Pierre I Karakiewicz, Michael Rink, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|February 21, 2014
Re-assessment of 30-, 60- and 90-day mortality rates in non-metastatic prostate cancer patients treated either with radical prostatectomy or radiation therapyJens Hansen, Giorgio Gandaglia, Marco Bianchi, et al.
The Journal of Urology|August 18, 2009
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasisGiovanni Lughezzani, Claudio Jeldres, Hendrik Isbarn, et al.
BMC Cancer|August 18, 2016
Heterogeneity of ERG expression in prostate cancer: a large section mapping study of entire prostatectomy specimens from 125 patientsMaria-Christina Tsourlakis, Annegret Stender, Alexander Quaas, et al.
The Prostate|May 19, 2021
Non-cancer mortality in elderly prostate cancer patients treated with combination of radical prostatectomy and external beam radiation therapyMike Wenzel, Christoph Würnschimmel, Francesco Chierigo, et al.
Journal of Endourology|April 2, 2019
Contemporary National Assessment of Robot-Assisted Surgery Rates and Total Hospital Charges for Major Surgical Uro-Oncological Procedures in the United StatesElio Mazzone, Francesco A Mistretta, Sophie Knipper, et al.
Journal of Endourology|February 7, 2014
Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatmentsGiorgio Gandaglia, Firas Abdollah, Jim Hu, et al.
Pageof 93